ConductScience.org, home

Paper36920736

In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins.

Leidenmühler P and 6 others. Drug Deliv Transl Res, 2023. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins. Papers, record 36920736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36920736

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins.
PubMed
Journal
Drug Deliv Transl Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2023-08-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leidenmühler PPeter
2Höfinghoff JJoris
3Haider NNorbert
4Brachtl GGerald
5Weiller MMarkus
6Bilic IIvan
7Gangadharan BBagirath

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HyaluronoglucosaminidaseMajor topic
Immunologic Deficiency SyndromesMajor topic
Humans
Animals
Swine
Immunoglobulins
Infusions, Subcutaneous
Injections, Subcutaneous

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121199100
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.
J Peripher Nerv Syst2010https://conductscience.org/library/papers/21199100PubMed
225787031Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model.Drug Deliv Transl Res2012https://conductscience.org/library/papers/25787031PubMed
327747583Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis.Rheumatol Ther2016https://conductscience.org/library/papers/27747583PubMed
415480339Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.J Allergy Clin Immunol2004https://conductscience.org/library/papers/15480339PubMed
56112565High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.Lancet1981https://conductscience.org/library/papers/6112565PubMed
617911466Intravenous immunoglobulin and autoimmune disease.Ann N Y Acad Sci2007https://conductscience.org/library/papers/17911466PubMed
733469268Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements.Drug Des Devel Ther2021https://conductscience.org/library/papers/33469268PubMed
87540602A comparison of the patient-borne costs of therapy with gamma globulin given at the hospital or at home.Int J Technol Assess Health Care1995https://conductscience.org/library/papers/7540602PubMed
925693652Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.AAPS PharmSciTech2015https://conductscience.org/library/papers/25693652PubMed
1016783465Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases.J Clin Immunol2006https://conductscience.org/library/papers/16783465PubMed
116209513High-dose intravenous gammaglobulin for Kawasaki disease.Lancet1984https://conductscience.org/library/papers/6209513PubMed
1218842292Intravenous immunoglobulin: adverse reactions and management.J Allergy Clin Immunol2008https://conductscience.org/library/papers/18842292PubMed
1320674834Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies.Ann Allergy Asthma Immunol2010https://conductscience.org/library/papers/20674834PubMed
1419114702Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis.J Clin Oncol2009https://conductscience.org/library/papers/19114702PubMed
1518937372Quantitation of protein particles in parenteral solutions using micro-flow imaging.J Pharm Sci2009https://conductscience.org/library/papers/18937372PubMed
161712881Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion.Lancet1991https://conductscience.org/library/papers/1712881PubMed
1717683255Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration.Expert Opin Drug Deliv2007https://conductscience.org/library/papers/17683255PubMed
1823456255Bioavailability of IgG administered by the subcutaneous route.J Clin Immunol2013https://conductscience.org/library/papers/23456255PubMed
1919883424Subcutaneous immunoglobulin: opportunities and outlook.Clin Exp Immunol2009https://conductscience.org/library/papers/19883424PubMed
207513227Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency.Immunodeficiency1993https://conductscience.org/library/papers/7513227PubMed

See all 35 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
40103597Patient Preferences for Faster Home-Based Subcutaneous Immunoglobulin Infusion Therapy and the Effect on Adverse Events.Patient Prefer Adherence2025https://conductscience.org/library/papers/40103597PubMed
38129731A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults.J Clin Immunol2023https://conductscience.org/library/papers/38129731PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SPAM16677PubTator's text mininghttps://conductscience.org/library/genes/6677

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36920736

GET https://conductscience.org/api/papers/v1/36920736/references?page=2